A detailed history of Winthrop Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Winthrop Capital Management, LLC holds 2,627 shares of ABBV stock, worth $461,248. This represents 0.25% of its overall portfolio holdings.

Number of Shares
2,627
Previous 2,627 -0.0%
Holding current value
$461,248
Previous $451,000 15.08%
% of portfolio
0.25%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $9,132 - $10,664
59 Added 2.3%
2,627 $451,000
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $8,949 - $10,197
56 Added 2.23%
2,568 $468,000
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $345,651 - $389,284
2,512 New
2,512 $389 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Winthrop Capital Management, LLC Portfolio

Follow Winthrop Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winthrop Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winthrop Capital Management, LLC with notifications on news.